Whole exome sequencing reveals a pathogenic homozygous CLDN16 mutation in a 17-year-old patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis: A case report
Abstract
RATIONALE: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare autosomal recessive renal tubular disorder caused by mutations in the CLDN16 or CLDN19 genes. This case demonstrates the critical role of whole-exome sequencing (WES) in diagnosing FHHNC, particularly when novel mutations, such as the homozygous CLDN16 variant (c.351G > T, p.W117C) found in this patient, are identified, which expands the genetic understanding of this condition.
PATIENT CONCERNS: A 17-year-old female presented with an 8-month history of persistent neck, shoulder, and upper limb pain that had worsened over the past month. Despite initial treatment for cervical degenerative disease at local hospitals, her symptoms showed minimal improvement. She also exhibited growth retardation, with a height of 145 cm (-2 SD), and experienced recurrent urinary tract infections, although she reported no visual disturbances or neurological symptoms.
DIAGNOSES: Laboratory tests revealed hypomagnesemia and elevated parathyroid hormone levels. Imaging studies confirmed bilateral nephrocalcinosis and a medullary sponge kidney. Genetic testing using WES identified a homozygous pathogenic mutation in CLDN16 (c.351G > T), which was further validated by Sanger sequencing in the patient and her heterozygous parents.
INTERVENTIONS: During hospitalization, the patient received intravenous magnesium sulfate (2.5 g/day), oral calcium carbonate with vitamin D3 supplementation, and levofloxacin for…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.